Expanded Ozempic approval in the U.S. could transform how doctors treat patients with chronic kidney disease, which involves ...

In its early stages, kidney disease may not cause any symptoms or signs. However, as it progresses, it can cause symptoms such as itchy skin, pruritus, and a rash. Around 35.5 million adults in ...

The burden is particularly high in urban areas, where the prevalence reaches 15.2 percent compared to just 2.0 percent in ...

Semaglutide is now approved for reducing the risk for worsening kidney disease and cardiovascular death in adults with ...

The Food and Drug Administration approved Ozempic to be used to lessen the risk of kidney disease from getting worse, ...

The Food and Drug Administration has approved Ozempic ® (semaglutide) to reduce the risk of sustained estimated glomerular ...

Tea consumption offers protective effects on mortality among patients with chronic kidney disease, according to study findings.

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...

The discontinuation comes after the investigational drug, volenrelaxin, failed a related heart failure study in an ...

CKD can lead to severe complications like anemia, uremic gastroenteritis, and renal secondary hyperparathyroidism. Early ...